Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Gulba

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Zeitschrift Fur Kardiologie|January 1, 1993
[The value of late thrombolytic perfusion in acute myocardial infarct]D C Gulba
Deutsche Medizinische Wochenschrift (1946)|January 3, 1992
[Heparin therapy in coronary disease]D C Gulba
Der Internist|May 1, 1992
[Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?]D C Gulba
Der Internist|June 1, 1996
[Biochemical, pharmacologic and clinical properties of new thrombolytic agents]D C Gulba
Thrombosis and Haemostasis|December 22, 1999
Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approachD C Gulba
Zeitschrift Fur Kardiologie|January 1, 1993
[Thrombolytic therapy of pulmonary embolism--a therapeutic alternative?]D C Gulba
Deutsche Medizinische Wochenschrift (1946)|January 29, 1993
[A central venous catheter in acute myocardial infarct?]D C Gulba
Herz|February 1, 1996
-Anticoagulant drugs-D C Gulba
Deutsche Medizinische Wochenschrift (1946)|September 19, 2013
[Triple therapy for patients with stent and atrial fibrillation? Yes!]D C Gulba
Zeitschrift Fur Kardiologie|July 17, 2001
[Significance of the uPA/uPAR system for development of arteriosclerosis and restenosis]A Kusch, D C Gulba
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Zeitschrift Fur Kardiologie|January 1, 1993
[The value of late thrombolytic perfusion in acute myocardial infarct]D C Gulba
Deutsche Medizinische Wochenschrift (1946)|January 3, 1992
[Heparin therapy in coronary disease]D C Gulba
Der Internist|May 1, 1992
[Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?]D C Gulba
Der Internist|June 1, 1996
[Biochemical, pharmacologic and clinical properties of new thrombolytic agents]D C Gulba
Thrombosis and Haemostasis|December 22, 1999
Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approachD C Gulba
Zeitschrift Fur Kardiologie|January 1, 1993
[Thrombolytic therapy of pulmonary embolism--a therapeutic alternative?]D C Gulba
Deutsche Medizinische Wochenschrift (1946)|January 29, 1993
[A central venous catheter in acute myocardial infarct?]D C Gulba
Herz|February 1, 1996
-Anticoagulant drugs-D C Gulba
Deutsche Medizinische Wochenschrift (1946)|September 19, 2013
[Triple therapy for patients with stent and atrial fibrillation? Yes!]D C Gulba
Zeitschrift Fur Kardiologie|July 17, 2001
[Significance of the uPA/uPAR system for development of arteriosclerosis and restenosis]A Kusch, D C Gulba
Pageof 6